Analyst Reco. Cronos Group Inc.

Equities

CRON

CA22717L1013

Delayed Toronto S.E. Other stock markets 19:48:14 29/04/2024 BST			5-day change	1st Jan Change
3.45 ^CAD	-2.27%		+7.14%	+24.55%

04-02	Cannabis Stocks: Wedbush Notes Florida Supreme Court Approved Proposed Amendment For Adult Use Cannabis to be Placed on the 2024 General Election Ballot	MT
03-25	Cronos Group Brief: Launching 'Lord Jones' Chocolate Fusions	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aurora, Canopy Among Cannabis Stocks Rising After Germany Passes Partial Legalization Law	03-22	MT
Bernstein Starts Cronos Group at Market Perform with CA$4.10 Price Target	02/11/22	MT
Barclays Adjusts Cronos Group's Price Target to $3.50 from $5, Maintains Equalweight Rating	30/09/22	MT
Cronos Group Price Target Raised to $7 at Raymond James	29/07/22	MT
CIBC Upgrades Cronos Group to Outperform From Neutral	12/05/22	MT
Raymond James Adjusts Cronos Group Price Target to $6 From $5, Maintains Outperform Rating	09/05/22	MT
Barclays Upgrades Cronos Group to Equalweight From Underweight	22/03/22	MT
Piper Sandler Lowers Cronos Target to US$3 on Cash Flow Outlook, Maintains Neutral Rating	07/03/22	MT
Piper Sandler Adjusts Cronos Group Price Target to $3 From $4, Maintains Neutral Rating	07/03/22	MT
CORRECTION : --Canaccord Genuity Adjusts Cronos Group's Price Target to CA$4.25 from CA$7, Maintains Sell Rating	22/02/22	MT
Canaccord Genuity Adjusts Cronos Group's Price Target to $4.25 from $7, Maintains Sell Rating	22/02/22	MT
Stifel Adjusts Cronos Group's Price Target to $4 From $6.50, Reiterates Hold Rating	22/02/22	MT
Piper Sandler Adjusts Cronos Group's Price Target to $4 From $7, Maintains Neutral Rating	22/02/22	MT
Cronos Group Neutral Rating Reiterated by Piper Sandler Following Q3 Results, Q2 Restatement	18/02/22	MT
Jefferies Upgrades Cronos Group to Hold From Underperform	27/01/22	MT
Cannabis Stocks Brief: Barclays Initiates Underwhelming Ratings on Canada Cannabis Cos Due To Difficulties In Having US Multi-State Operations, Citing Canopy Growth Recent Moves, BNN TV notes	23/11/21	MT
Cronos Brief: Initiated With Underweight Rating and Target of US$5 at Barclays, notes BNN TV	23/11/21	MT
Barclays Starts Cronos Group at Underweight With $5.50 Price Target	18/11/21	MT
Cannabis Brief: BNN Also Notes Sector Expected To Operate At An Annual Run Rate of Near $8-9 Billion Over Next Few Years, "Despite Profitability Challenges"	23/09/21	MT
Cannabis Brief: BNN Notes the Sector Operates At An Annual Run Rate of Near $4 Billion, Showing Market Continues To Grow	23/09/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Cronos Group Inc.

Equities

CRON

CA22717L1013

Analyst Reco.

Filters